Agilon Health, Inc.
AGL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $5 | $7 | $11 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $5 | $6 | $10 |
| Revenue | $6 | $4 | $2 | $2 |
| % Growth | 40.4% | 80.7% | 57% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0.1% | 1.6% | 4.7% | 4.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.6% | -3.9% | -3% | -23.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.3% | -6.1% | -4.5% | -26.7% |
| EPS Diluted | -0.63 | -0.64 | -0.26 | -1.09 |
| % Growth | 1.6% | -146.2% | 76.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |